The future of anticoagulation clinics

Journal of Thrombosis and Thrombolysis

Volumn 16, Issue 1-2, 2003, Pages 55-59

  Macik, B Gail ^a  

^a UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

Author keywords

Anticoagulation clinic; Anticoagulation management; Warfarin

Indexed keywords

ANTICOAGULANT AGENT; COUMARIN DERIVATIVE; WARFARIN;

ANTICOAGULANT THERAPY; ARTICLE; BLOOD ANALYSIS; CLINICAL PRACTICE; COMORBIDITY; COMPUTER PROGRAM; DIET; DOCTOR PATIENT RELATION; DRUG DOSE REGIMEN; DRUG INDICATION; FREQUENCY ANALYSIS; HEALTH CARE QUALITY; HEALTH CENTER; HUMAN; INTERPERSONAL COMMUNICATION; MEDICAL PRACTICE; OUTPATIENT CARE; PATIENT COMPLIANCE; PATIENT EDUCATION; PATIENT MONITORING; PHARMACODYNAMICS; PRACTICE GUIDELINE; PRIORITY JOURNAL; RECURRENT DISEASE; REIMBURSEMENT; SELF CARE; THROMBOEMBOLISM; WORKLOAD;

AMBULATORY CARE FACILITIES; ANTICOAGULANTS; FORECASTING; HUMANS; SELF CARE; WARFARIN;

EID: 1842778867     PISSN: 09295305     EISSN: None     Source Type: Journal    
DOI: 10.1023/B:THRO.0000014594.52685.33     Document Type: Article

References (32)

1. Ansell J, Hirsh J, Dalen J, et al. Managing oral anticoagulant therapy. Chest 2001;119:22S-38S.
2. Bush J. Reducing risks for patients receiving warfarin. Fam Pract Manag 2002;9:35-38.
3. Hirsh J, Fuster V, Ansell J, Halperin JL. American Heart Association/American College of Cardiology Foundation guide to warfarin therapy. Circulation 2003;107:1692-1711.
4. Matchar DB, Samsa GP, Cohen SJ, Oddone EZ, Jurgelski AE. Improving the quality of anticoagulation of patients with atrial fibrillation in managed care organizations: Results of the managing anticoagulation services trial. Am J Med 2002;113:42-51.
5. Samsa GP, Matchar DB, Goldstein LB, et al. Quality of anticoagulation management among patients with atrial fibrillation: Results of a review of medical records from 2 communities. Arch Intern Med 2000;160:967-973.
6. Hirsh J, Dalen J, Anderson DR, et al. Oral anticoagulants: Mechanism of action, clinical effectiveness, and optimal therapeutic range. Chest 2001;119:8S-21S.
7. Beyth RJ, Quinn LM, Landefeld CS. Prospective evaluation of an index for predicting the risk of major bleeding in outpatients treated with warfarin. Am J Med 1998;105:91-99.
8. Fihn SD, McDonell M, Martin D, et al. Risk factors for complications of chronic anticoagulation. A multicenter study. Warfarin Optimized Outpatient Follow-up Study Group. Ann Intern Med 1993;118:511-520.
9. Landefeld CS, Beyth RJ. Anticoagulant-related bleeding: Clinical epidemiology, prediction, and prevention. Am J Med 1993;95:315-328.
10. Palareti G, Leali N, Coccheri S, et al. Bleeding complications of oral anticoagulant treatment: An inception-cohort, prospective collaborative study (ISCOAT). Italian Study on Complications of Oral Anticoagulant Therapy. Lancet 1996;348:423-428.
11. Ansell JE. Anticoagulation management clinics for the out-patient control of oral anticoagulants. Curr Opin Pulm Med 1998;4:215-219.
12. Ansell JE, Buttaro ML, Thomas OV, Knowlton CH. Consensus guidelines for coordinated outpatient oral anticoagulation therapy management. Anticoagulation Guidelines Task Force. Ann Pharmacother 1997;31:604-615.
13. Chiquette E, Amato MG, Bussey HI. Comparison of an anticoagulation clinic with usual medical care: Anticoagulation control, patient outcomes, and health care costs. Arch Intern Med 1998;158:1641-1647.
14. Caffee AE, Teichman PG. Improving anticoagulation management at the point of care. Fam Pract Manag 2002;9:35-37.
15. Tripodi A, Arbini AA, Chantarangkul V, Bettega D, Mannucci PM. Are capillary whole blood coagulation monitors suitable for the control of oral anticoagulant treatment by the international normalized ratio? Thromb Haemost 1993;70:921-924.
16. Gosselin RC, Owings JT, Larkin E, White RH, Hutchinson R, Branch J. Monitoring oral anticoagulant therapy with point-of-care devices: Correlations and caveats. Clin Chem 1997;43:1785-1786.
17. Tripodi A, Chantarangkul V, Bressi C, Mannucci PM. International sensitivity index calibration of the near-patient testing prothrombin time monitor, ProTime. Am J Clin Pathol 2003;119:241-245.
18. Tripodi A, Chantarangkul V, Mannucci P. Near-patient testing devices to monitor oral anticoagulant therapy. Br J Haematol 2001;113:847-852.
19. van den Besselaar AM. Accuracy, precision, and quality control for point-of-care testing of oral anticoagulation. J Thromb Thrombolysis 2001;12:35-40.
20. Ansell JE, Hughes R. Evolving models of warfarin management: Anticoagulation clinics, patient self-monitoring, and patient self-management. Am Heart J 1996;132:1095-1100.
21. Beyth RJ, Quinn L, Landefeld CS. A multicomponent intervention to prevent major bleeding complications in older patients receiving warfarin. A randomized, controlled trial. Ann Intern Med 2000;133:687-695.
22. Ansell JE, Patel N, Ostrovsky D, Nozzolillo E, Peterson AM, Fish L. Long-term patient self-management of oral anticoagulation. Arch Intern Med 1995;155:2185-2189.
23. Hasenkam JM, Kimose HH, Knudsen L, et al. Self management of oral anticoagulant therapy after heart valve replacement. Eur J Cardiothorac Surg 1997;11:935-942.
24. Lafata JE, Martin SA, Kaatz S, Ward RE. Anticoagulation clinics and patient self-testing for patients on chronic warfarin therapy: A cost-effectiveness analysis. J Thromb Thrombolysis 2000;9(Suppl 1):S13-S19.
25. Leaning KE, Ansell JE. Advances in the Monitoring of Oral Anticoagulation: Point-of-Care Testing, Patient Self-Monitoring, and Patient Self-Management. J Thromb Thrombolysis 1996;3:377-383.
26. Sawicki PT. A structured teaching and self-management program for patients receiving oral anticoagulation: A randomized controlled trial. Working Group for the Study of Patient Self-Management of Oral Anticoagulation. JAMA 1999;281:145-150.
27. Horstkotte D, Piper C, Wiemer M. Optimal Frequency of Patient Monitoring and Intensity of Oral Anticoagulation Therapy in Valvular Heart Disease. J Thromb Thrombolysis 1998;5(Suppl 1):19-24.
28. Shojania K, Duncan B, McDonald E, et al. Making Health Care Safer: A Critical Analysis of Patient Safety. Vol. AHRQ publication # 01-E058. Rockville, MD: Agency for Healthcare Research and Quality, 2001.
29. Taborski U, Wittstamm FJ, Bernardo A. Cost-effectiveness of self-managed anticoagulant therapy in Germany. Semin Thromb Hemost 1999;25:103-107.
30. Ryan PJ, Gilbert M, Rose PE. Computer control of anticoagulant dose for therapeutic management. BMJ 1989;299:1207-1209.
31. Poller L, Wright D, Rowlands M. Prospective comparative study of computer programs used for management of warfarin. J Clin Pathol 1993;46:299-303.
32. Poller L, Shiach CR, MacCallum PK, et al. Multicentre randomised study of computerised anticoagulant dosage. European Concerted Action on Anticoagulation. Lancet 1998;352:1505-1509.